Saturday, January 3, 2026

Palantir Stock Is Up 145% in 2025. What The Data Tells Us to Expect for the New Year.

Palantir (PLTR) stock was lucrative for investors this year as the company’s commercial unit continued to grow rapidly while its government segment remained a reliable source of cash.

Last month, the Nasdaq-listed firm raised its full-year outlook as well, now seeing revenue coming in at about $4.4 billion, reflecting management’s confidence in continued momentum ahead.

At the time of writing, Palantir shares are already up more than 145% versus the start of 2025.

www.barchart.com
www.barchart.com

PLTR finished its third financial quarter with commercial remaining deal value (RDV) up roughly 200% year-on-year, indicating robust demand for its platforms among U.S. enterprises.

Sure, the stock isn’t inexpensive heading into 2026, but continued upside in Foundry, Gotham, and Apollo use cases suggest the premium may be justified.

On the “Rule of 40” – a key SaaS industry benchmark – the data analytics giant sits at a staggering 94 currently, underscoring its rare balance of growth and profitability.

Even from a technical perspective, PLTR stock is attractive, with a 100-day relative strength index (RSI) at nearly 55, reinforcing the upward momentum isn’t out of juice just yet.

Bank of America analysts reiterated their “Buy” rating on Palantir stock last week after the Denver-headquartered firm secured a two-year, $48 million U.S. Navy ShipOS contract.

According to the investment firm, evolving use cases will grow margin, unlocking material further upside in the AI stock over time.

In 2026, BofA sees it hitting $255, indicating potential upside of another 30% from current levels.

Options traders seem to agree with the bank as well. According to Barchart, derivatives contracts expiring late March suggest Palantir shares could be trading at north of $225 over the next three months.

Not all investment firms share Bank of America’s optimism on PLTR stock, though.

The consensus rating on Palantir shares currently sits at “Hold” only, with the mean target of about $193 already in line with the price at which they are trading currently.

Source link

Hot this week

Tern Pharmaceuticals (TERN) Soars 630% on CML Treatment Best-in-Class Potential

We recently published 10 Market Stars...

How EchoStar (SATS) Rocketed 375% From Near-Bankruptcy in 2025

We recently published 10 Market Stars...

Wall Street edges higher in a wobbly start to 2026

NEW YORK (AP) — U.S. stocks...

Vice Stocks Enter ’26 With a Harsh Hangover

It’s easy to see how investors...

The rise of ‘finfluencers:’ Can you really trust financial advice on social media?

Financial influencers — or "finfluencers" —...

Topics

Related Articles

Popular Categories